Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (181-190 of 250) with videos related to

Pageof 25
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2023
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S MiceMarion Moreews, Anne-Laure Mathieu, Kevin Pouxvielh, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunityBenjamin Fournier, Maud Tusseau, Marine Villard, et al.
The Journal of Experimental Medicine|August 20, 2021
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJonathan Lopez, Marine Mommert, William Mouton, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Rheumatology (Oxford, England)|April 27, 2026
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive studyDorian Bigey-Frau, Damia Leguevaques, Heloise Reumaux, et al.
The Journal of Experimental Medicine|August 6, 2021
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJonathan Lopez, Marine Mommert, William Mouton, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Journal of Clinical Immunology|January 29, 2022
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory SyndromeHassan Abolhassani, Nils Landegren, Paul Bastard, et al.
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
La Revue De Medecine Interne|October 25, 2024
French protocol for diagnosis and management of Cogan's syndromeLaurent Arnaud, Alexandra Audemard-Verger, Alexandre Belot, et al.
Pageof 25

Showing results (181-190 of 250) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2023
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S MiceMarion Moreews, Anne-Laure Mathieu, Kevin Pouxvielh, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunityBenjamin Fournier, Maud Tusseau, Marine Villard, et al.
The Journal of Experimental Medicine|August 20, 2021
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJonathan Lopez, Marine Mommert, William Mouton, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Rheumatology (Oxford, England)|April 27, 2026
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive studyDorian Bigey-Frau, Damia Leguevaques, Heloise Reumaux, et al.
The Journal of Experimental Medicine|August 6, 2021
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNsJonathan Lopez, Marine Mommert, William Mouton, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Journal of Clinical Immunology|January 29, 2022
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory SyndromeHassan Abolhassani, Nils Landegren, Paul Bastard, et al.
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
La Revue De Medecine Interne|October 25, 2024
French protocol for diagnosis and management of Cogan's syndromeLaurent Arnaud, Alexandra Audemard-Verger, Alexandre Belot, et al.
Pageof 25